Quintrio
Home

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Cel-Sci Corporation

CVM

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Last trade $1.89
Day change +$0.225 (+13.55%)
Day range $1.70 – $2.12
Volume 1,125,278
Market cap $29M

Open XASE

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$29.2M
Price / earnings
—
Price / book
2.67×
Price / sales
—
EV / sales
—
EV / EBITDA
-1.57×

Profitability

Earnings per share
-$1.29
Return on assets
-106.31%
Return on equity
-207.23%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.57×
Current ratio
1.48×
Quick ratio
1.42×
Cash ratio
1.29×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$16.75M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CVM, quarterly periods
Line itemQ3 FY2026 Jun 30, 2026Q2 FY2026 Mar 31, 2026Q1 FY2026 Dec 31, 2025Q4 FY2025 Sep 30, 2025Q3 FY2025 Jun 30, 2025Q2 FY2025 Mar 31, 2025Q1 FY2025 Dec 31, 2024Q4 FY2024 Sep 30, 2024
Revenue$0$0$0$0$0$0$0$0
Cost of revenue$0$0$0$0$0$0$0$0
Gross profit$0$0$0$0$0$0$0$0
Selling, general and administrative$1.91M$1.56M$1.69M$2.33M$1.75M$2.38M$2.46M$1.64M
Research and development$3.65M$3.77M$3.68M$3.7M$3.74M$4.01M$4.43M$4.48M
Total operating expenses$5.56M$5.33M$5.37M$6.03M$5.49M$6.39M$6.89M$6.12M
Operating income-$5.56M-$5.33M-$5.37M-$6.03M-$5.49M-$6.39M-$6.89M-$6.12M
Interest expense-$110.24K$0-$87.79K-$128.51K-$172.05K$0-$170.1K-$174.57K
Income before taxes-$5.67M-$5.47M-$5.47M-$6.1M-$5.66M-$6.57M-$7.07M-$6.11M
Income taxes$0$0$0$0$0$0$0$0
Net income-$5.67M-$5.47M-$5.47M-$6.1M-$5.66M-$6.57M-$7.07M-$6.11M
Net income attributable to common shareholders-$5.67M-$5.47M-$5.47M-$6.1M-$5.66M-$6.57M-$7.07M-$6.11M
EBITDA-$4.61M-$4.37M-$4.4M-$5.07M-$4.53M-$5.42M-$5.9M-$5.13M
Basic earnings per share-$0.47-$0.67-$0.68-$0.86-$1.36-$2.33-$3.25-$2.97
Diluted earnings per share-$0.47-$0.67-$0.68-$0.86-$1.36-$2.33-$3.25-$2.97

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit. U Power shares dipped 54% to $0.7090 on Monday. Here are some other stocks moving in today's mid-day session. Gainers EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares jumped 211.3% to $20.58 after the company announced the Phase 2 DAVIO 2 trial of EYP-1901 in wet AMD achieved all primary and secondary endpoints. Hawaiian Holdings, Inc. (NASDAQ: HA) shares climbed 187% to $14.03 after Alaska Air Group, Inc. (NYSE: ALK) announced plans to acquire the company in a deal worth $1.9 billion. Alterity Therapeutics Limited (NASDAQ: ATHE) shares climbed 156% to $4.25 after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's Disease Conference 2023. SilverSun Technologies, Inc. (NASDAQ: SSNT) gained 142.7% to $8.91 after the company announced Jacobs Private Equity II and minority co-investors will invest $1 billion in the company. Bit Brother Limited (NASDAQ: BETS) rose 86.3% to $0.0723 after surging 43% on Friday. Bit Brother said it purchased 3300 units of Antminer S19 miners, injecting powerful momentum into its Bitcoin mining operations. Lucy Scientific Discovery Inc. (NASDAQ: LSDI) shares jumped 72.2% to $0.3530. View, Inc. (NASDAQ: VIEW) gained 52.3% to $1.5701. Mawson Infrastructure Group, Inc. (NASDAQ: MIGI) rose 29.8% to $1.17. Marpai, Inc. (NASDAQ: MRAI) jumped 28.3% to $1.9250. CEL-SCI Corporation (NYSE: CVM) surged 25.6% to $2.6009. The UK'S National Institute for Health and Care Excellence selected CEL-SCI's Multikine as a potential new ...

Benzinga

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. The Singing Machine Company, Inc. (NASDAQ: MICS) shares surged 32% to $2.10 after the company announced it launched a new party accessory product line available at Walmart. Biophytis S.A. (NASDAQ: BPTS) gained 29% to $2.78 after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. iCAD, Inc. (NASDAQ: ICAD) rose 21.3% to $2.50. iCAD signed strategic commercial agreement with Radiology Partners, the nation's largest radiology practice. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares climbed 18.7% to $0.3121 after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients. Interlink Electronics, Inc. (NASDAQ: LINK) shares climbed 17.4% to $12.65. Innodata Inc. (NASDAQ: INOD) gained 16.2% to $12.43. D-Wave Quantum Inc. (NYSE: QBTS) climbed 15.1% to $2.9585. Benchmark, on Monday, maintained a Buy rating on the stock and raised its price target from $2 to $3. Advent Technologies Holdings, Inc. (NASDAQ: ADN) gained 14.4% to $0.9595. Advanced Emissions Solutions, Inc. (NASDAQ: ADES) rose 13.4% to $1.8061. Advanced Emissions Solutions named Robert Rasmus to succeed Greg Marken as President and CEO on July 17, 2023. Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 13.4% to $5.26 in pre-market trading after jumping 27% on Monday. Altice USA, Inc. ...

Benzinga

US Stocks Mixed; Bank of America Tops Q2 Views

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to 14,190.20. The S&P 500, also fell, declining, 0.05% to 4,520.47. Check This Out: Ethereum Slides But Remains Above $1,900; 1inch Network Becomes Top Loser   Leading and Lagging Sectors Energy shares climbed by 0.6% on Tuesday. In trading on Tuesday, information technology shares fell by 0.5%.   Top Headline Bank of America Corp (NYSE: BAC) reported better-than-expected second-quarter results. Bank of America reported a second-quarter FY23 net income growth of 19% year-over-year to $7.4 billion. EPS for the quarter was $0.88, compared to $0.73 in 2Q22, beating the consensus of $0.84. Revenue increased 11% Y/Y to $25.33 billion, beating the consensus of $25.05 billion.   Equities Trading UP The Singing Machine Company, Inc. (NASDAQ: MICS) shares shot up 40% to $2.21 after the company announced it launched a new party accessory product line available at Walmart. Shares of Biophytis S.A. (NASDAQ: BPTS) got a boost, shooting 45% to $3.1185 after the company signed ...

Benzinga

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares gained 41.8% to $0.3729 in pre-market trading after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients. Karyopharm Therapeutics Inc. (NASDAQ: KPTI) rose 26.1% to $1.93 in pre-market trading after the company received FDA Fast Track Designation for Selinexor for Myelofibrosis. Rubicon Technologies, Inc. (NYSE: RBT) shares rose 19.9% to $0.47 in pre-market trading after surging 19% on Monday. Taoping Inc. (NASDAQ: TAOP) shares gained 14.4% to $0.5999 in pre-market trading after declining 7% on Monday. Vapotherm, Inc. (NYSE: VAPO) shares rose 13.4% to $0.4364 in pre-market trading after gaining 8% on Monday. Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 13.4% to ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
May 20, 20251-for-30reverse split
Jun 15, 20171-for-25reverse split
Sep 25, 20131-for-10reverse split